UBS AM’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Buy |
175,416
+63,137
| +56% | +$410K | ﹤0.01% | 2355 |
|
|
2025
Q1 | $890K | Buy |
112,279
+36,700
| +49% | +$291K | ﹤0.01% | 2358 |
|
|
2024
Q4 | $958K | Buy |
75,579
+10,386
| +16% | +$132K | ﹤0.01% | 2380 |
|
|
2024
Q3 | $908K | Sell |
65,193
-4,537
| -7% | -$63.2K | ﹤0.01% | 2443 |
|
|
2024
Q2 | $961K | Buy |
69,730
+31,851
| +84% | +$439K | ﹤0.01% | 2386 |
|
|
2024
Q1 | $626K | Buy |
37,879
+23,579
| +165% | +$390K | ﹤0.01% | 2213 |
|
|
2023
Q4 | $209K | Buy |
+14,300
| New | +$209K | ﹤0.01% | 2485 |
|